Literature DB >> 33657094

MITOL-dependent ubiquitylation negatively regulates the entry of PolγA into mitochondria.

Mansoor Hussain1, Aftab Mohammed1, Shabnam Saifi1, Aamir Khan1, Ekjot Kaur1, Swati Priya1, Himanshi Agarwal1, Sagar Sengupta1.   

Abstract

Mutations in mitochondrial replicative polymerase PolγA lead to progressive external ophthalmoplegia (PEO). While PolγA is the known central player in mitochondrial DNA (mtDNA) replication, it is unknown whether a regulatory process exists on the mitochondrial outer membrane which controlled its entry into the mitochondria. We now demonstrate that PolγA is ubiquitylated by mitochondrial E3 ligase, MITOL (or MARCH5, RNF153). Ubiquitylation in wild-type (WT) PolγA occurs at Lysine 1060 residue via K6 linkage. Ubiquitylation of PolγA negatively regulates its binding to Tom20 and thereby its mitochondrial entry. While screening different PEO patients for mitochondrial entry, we found that a subset of the PolγA mutants is hyperubiquitylated by MITOL and interact less with Tom20. These PolγA variants cannot enter into mitochondria, instead becomes enriched in the insoluble fraction and undergo enhanced degradation. Hence, mtDNA replication, as observed via BrdU incorporation into the mtDNA, was compromised in these PEO mutants. However, by manipulating their ubiquitylation status by 2 independent techniques, these PEO mutants were reactivated, which allowed the incorporation of BrdU into mtDNA. Thus, regulated entry of non-ubiquitylated PolγA may have beneficial consequences for certain PEO patients.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33657094      PMCID: PMC7959396          DOI: 10.1371/journal.pbio.3001139

Source DB:  PubMed          Journal:  PLoS Biol        ISSN: 1544-9173            Impact factor:   8.029


  51 in total

1.  A novel mitochondrial ubiquitin ligase plays a critical role in mitochondrial dynamics.

Authors:  Ryo Yonashiro; Satoshi Ishido; Shinkou Kyo; Toshifumi Fukuda; Eiji Goto; Yohei Matsuki; Mari Ohmura-Hoshino; Kiyonao Sada; Hak Hotta; Hirohei Yamamura; Ryoko Inatome; Shigeru Yanagi
Journal:  EMBO J       Date:  2006-07-27       Impact factor: 11.598

2.  Mitochondrial E3 ligase MARCH5 regulates FUNDC1 to fine-tune hypoxic mitophagy.

Authors:  Ziheng Chen; Lei Liu; Qi Cheng; Yanjun Li; Hao Wu; Weilin Zhang; Yueying Wang; Sheikh Arslan Sehgal; Sami Siraj; Xiaohui Wang; Jun Wang; Yushan Zhu; Quan Chen
Journal:  EMBO Rep       Date:  2017-01-19       Impact factor: 8.807

3.  Novel role of p53 in maintaining mitochondrial genetic stability through interaction with DNA Pol gamma.

Authors:  Geetha Achanta; Ryohei Sasaki; Li Feng; Jennifer S Carew; Weiqin Lu; Helene Pelicano; Michael J Keating; Peng Huang
Journal:  EMBO J       Date:  2005-09-15       Impact factor: 11.598

4.  Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations.

Authors:  Young-Sam Lee; W Dexter Kennedy; Y Whitney Yin
Journal:  Cell       Date:  2009-10-16       Impact factor: 41.582

5.  Subnormal levels of POLγA cause inefficient initiation of light-strand DNA synthesis and lead to mitochondrial DNA deletions and progressive external ophthalmoplegia [corrected].

Authors:  Sara Roos; Bertil Macao; Javier Miralles Fusté; Christopher Lindberg; Elisabeth Jemt; Elisabeth Holme; Ali-Reza Moslemi; Anders Oldfors; Maria Falkenberg
Journal:  Hum Mol Genet       Date:  2013-02-27       Impact factor: 6.150

6.  Mitochondrial protein quality control by the proteasome involves ubiquitination and the protease Omi.

Authors:  Susanne Radke; Harish Chander; Patrick Schäfer; Gregor Meiss; Rejko Krüger; Jörg B Schulz; Doris Germain
Journal:  J Biol Chem       Date:  2008-03-24       Impact factor: 5.157

7.  Mitochondrial ubiquitin ligase MITOL ubiquitinates mutant SOD1 and attenuates mutant SOD1-induced reactive oxygen species generation.

Authors:  Ryo Yonashiro; Ayumu Sugiura; Misako Miyachi; Toshifumi Fukuda; Nobuko Matsushita; Ryoko Inatome; Yoshinobu Ogata; Takehiro Suzuki; Naoshi Dohmae; Shigeru Yanagi
Journal:  Mol Biol Cell       Date:  2009-09-09       Impact factor: 4.138

8.  Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase.

Authors:  Stefanie Peter; Jennyfer Bultinck; Kevin Myant; Laura A Jaenicke; Susanne Walz; Judith Müller; Michael Gmachl; Matthias Treu; Guido Boehmelt; Carsten P Ade; Werner Schmitz; Armin Wiegering; Christoph Otto; Nikita Popov; Owen Sansom; Norbert Kraut; Martin Eilers
Journal:  EMBO Mol Med       Date:  2014-12       Impact factor: 12.137

9.  Mitofusin 1 is degraded at G2/M phase through ubiquitylation by MARCH5.

Authors:  Yong-Yea Park; Hyeseong Cho
Journal:  Cell Div       Date:  2012-12-20       Impact factor: 5.130

10.  USP14 deubiquitinates proteasome-bound substrates that are ubiquitinated at multiple sites.

Authors:  Byung-Hoon Lee; Ying Lu; Miguel A Prado; Yuan Shi; Geng Tian; Shuangwu Sun; Suzanne Elsasser; Steven P Gygi; Randall W King; Daniel Finley
Journal:  Nature       Date:  2016-04-13       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.